FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

28320511000001109: Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Jan 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1842821000001112 Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1842841000001119 Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Is a Ledipasvir 90mg / Sofosbuvir 400mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Has AMP Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) true Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Has specific active ingredient Ledipasvir false Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Has specific active ingredient Sofosbuvir false Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Has specific active ingredient Ledipasvir true Inferred relationship Existential restriction modifier
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) 28 tablet Has specific active ingredient Sofosbuvir true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start